Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07118280

Oral Health, Saliva Viscosity and Composition in Oculo-Pharyngeal Muscular Dystrophy (OPMD)

The goal of this observational study is to explore whether oral health and saliva viscosity and composition in Oculopharyngeal Muscular Dystrophy (OPMD) is different from control subjects.

The main questions it aims to answer are:

Do swallowing disturbances in OPMD adversely affect oral health? Is saliva thickness (viscosity) is increased in OPMD? Does saliva in OPMD contains biochemical markers of the disease?

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Sheba Medical Center

Ramat Gan, Israel

Location status: Recruiting

Location contact

Alex Zvulunov, MD, MHA

PRINCIPAL_INVESTIGATOR

Naama Study coordinator

CONTACT

[email protected]

+972552929006

Silvina Friedlander-Barenboim, DMD

SUB_INVESTIGATOR

About this study

The objectives of this observational study is to investigate oral health, saliva rheology and explore biochemical markers in OPMD. specifically to determine if anecdotal reports of "thick saliva" represent a previously unrecognized manifestation of the disease.

Oculo-pharyngeal muscular dystrophy (OPMD) is a rare, late-onset, hereditary (OMIM 164300) progressive degenerative muscle disease characterized by oro-pharyngeal dysphagia and eyelid ptosis and skeletal muscle weakness.

Oro-pharyngeal dysphagia is associated with impaired oral health in elderly patients in general, in patients with neurodegenerative diseases and in Parkinson's disease. Yet, oral health in OPMD has not been explored so far. Additionally, a notion in one report that more than half of patients with OPMD complained about "having thick saliva" has not triggered further research of saliva properties in OPMD.

OPMD patients enrolled in IsrOPMD registry at the multidisciplinary OPMD service at the Sheba Medical Center will be offered to participate in the study. Unaffected spouse or household member of each patient will be offered to serve as a control. Subjects younger than 18 years of age and those with any condition that may affect a composition of saliva were excluded from this study.

All study subjects will proceed a thorough stomatological examination documenting the number of decayed, missing and filled teeth (DMFT index), dryness of oral mucosa, presence of tongue coating, atrophic papillae, cleft or geographic tongue, gingival inflammation and gross saliva secretion, unstimulated whole saliva flow rate and saliva viscosity. Untargeted metabolomic analysis of the saliva will be performed.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with OPMD and their spouses or household members

Exclusion criteria

  • • Pregnancy or presence of any disease that may affect a composition of saliva

Treatment and study plan

Primary outcomes

  1. Saliva Viscosity

    Time frame: Upon enrollment in the study

    Viscosity of unstimulated whole saliva

Secondary outcomes

  1. Oral health indices

    Time frame: Upon enrollment in the study

    DMFT, presence of tongue coating, clinical appearance of saliva and saliva-related complains

Other outcomes

  1. Concentration of Metabolites in saliva

    Time frame: Upon enrollment in the study

    Differences in concentration of metabolites in unstimulated whole saliva of patients and control groups.

Study contacts

Contact information is provided by the study sponsor or research team.

Naama Study coordinator

CONTACT

[email protected]

+972 55 2929006

Sponsors and collaborators

Lead sponsor

Sheba Medical Center

Other Gov

Registry information

Official study title

Saliva Composition in Oculo-Pharyngeal Muscular Dystrophy (OPMD)

Important dates

Study start
2023
Primary completion
2027
Study completion
2027
First posted
Aug 12, 2025
Registry last updated
Jan 27, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.